Rare diseases Xagena
Aggiornamento in Medicina
Novo Nordisk has announced the submission of a Biologics License Applications ( BLA ) to the US Food and Drug Administration ( FDA ) and a Marketing Authorisation Application ( MAA ) to the European M ...
